Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE004813 |
ID: | TCMBANKHE004813 |
植物拉丁名: |
|
功能与主治: | To warm spleen, check diarrhea, warm kidney, reduce urine, secure essence./Spleen-stomach vacuity cold, vomiting and diarrhea, cold pain in abdomen, drooling, enuresis due to kidney vacuity, frequent urination, emission, white turbidity. |
药用植物名: | 益智仁 |
药用部位: | fruit |
药味: | Warm; Pungent |
经络: | Spleen; Kidney |
临床特征: | 1. Relieving the cyclophosphamide-induced leucopenia in mice.2. Inhibiting the biosynthesis of prostaglandin. |
治疗类型: | 补虚 |
TCM_ID_id: | 7655 |
TCMSP_id: | 803 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN001959 | oxyphyllacinol | 4-(3-hydroxy-7-phenylheptyl)-2-methoxyphenol; AC1NSZCZ | C20H26O3 | 314.46 | COC1=C(C=CC(=C1)CCC(CCCCC2=CC=CC=C2)O)O |
| TCMBANKIN003837 | artoglasin a | ||||
| TCMBANKIN005472 | yejunualactone | C32H40O8 | 552.7 g/mol | CC1=CCC2C1C3C(C(CC2(C)O)OC(=O)C)C4(CC56C=CC4(C5C7C(CCC6(C)O)C(=C)C(=O)O7)C)C(=O)O3 | |
| TCMBANKIN008879 | zinginerol | ||||
| TCMBANKIN012121 | 7-glucosylisokanin | ||||
| TCMBANKIN013951 | angeloylajadin | 330.41 | |||
| TCMBANKIN017993 | vitamin c | D01CWN; Cell C; Ronotec 100; P 1110; Suncoat VC 40; D-threo-hex-2-enoic acid gamma-lactone; Citrovit; 2-o-(beta-d-glucopyranosyl)-ascorbic acid_qt; Juvamine; SCHEMBL13468284; Vasc; CHEBI:51384; D-Lyxoascorbic acid; CHEMBL1253320; AK481251; Chewcee; D-xyloascorbic acid; C8DQ5M1Y1E; MLS001066386; AK322241; Ascorbic acid, D-; AC1LD8K5; E 300; Scorbu C; 10504-35-5; Ascorbicacid; l(+)-ascorbic acid; ZINC100006137; L-ascorbate (vitamin C); (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; (+)-Ascorbic acid; UNII-C8DQ5M1Y1E; Ascorbinsaure; Ceklin; VC 97; (2S)-2-[(1R)-1,2-bis(oxidanyl)ethyl]-4,5-bis(oxidanyl)furan-3-one; Vicin; L-ascorbate acid; L-ascorbic acid; L-dehydroascorbic acid; ascorbate; D-threo-hex-2-enono-1,4-lactone; Kangbingfeng; D-Ascorbic acid; Viscorin 100M; ZINC100028197; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxy-3-furanone; L-Ascorbic acid (8CI,9CI); Proscorbin Redoxon Ribena Ronotec 100; Hex-2-enonic acid gamma-lactone, L-threo; (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one; Ascorbic acid; DL-Ascorbic acid; AKOS000278050; Cebion, gamma-lactone; F91F7DA3-A3D5-4FB4-A6E7-C497C48D192A; GTPL4651; SMR000471843; Xyloascorbic acid, L-; Rontex 100; Rovimix C; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; A828310 | C6H8O6 | 176.12 | C(C(C1C(=C(C(=O)O1)O)O)O)O |
| TCMBANKIN018365 | trans-1-(4’-hydroxy-3’-methoxyphenyl)-7-phenylheqt-1-en-3one | ||||
| TCMBANKIN018631 | Izalpinin | Isalpinin; 3,5-dihydroxy-7-methoxy-2-phenyl-chromen-4-one; 3,5-dihydroxy-7-methoxy-2-phenylchromen-4-one; izalpinin; 4H-1-Benzopyran-4-one, 3,5-dihydroxy-7-methoxy-2-phenyl-; 3,5-dihydroxy-7-methoxy-2-phenyl-chromone; 480-14-8; 3,5-dihydroxy-7-methoxy-2-phenyl-4-chromenone | C16H12O5 | 284.26 | COC1=CC(=C2C(=C1)OC(=C(C2=O)O)C3=CC=CC=C3)O |
| TCMBANKIN019601 | chrysol | C1=CC=C2C(=C1)C=CC3=C2C=CC4=CC=CC=C43 | |||
| TCMBANKIN019860 | 1-Methyl-3-isopropoxy cyclohexane | SCHEMBL8295326; 1-methyl-3-propan-2-yloxycyclohexane; 1-methyl-3-isopropoxy cyclohexane; AC1NSYGG | C10H20O | 156.26 g/mol | CC1CCCC(C1)OC(C)C |
| TCMBANKIN019942 | vitamin e | vitamin-e; LS-187838; alpha-tocopherol; tocopherol; β-Tocopherol; α-tocopher | C29H50O2 | 430.7 g/mol | CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C |
| TCMBANKIN021392 | zingiberene | CHEMBL479020; 495-60-3; 1,3-Cyclohexadiene, 5-(1,5-dimethyl-4-hexenyl)-2-methyl-, (S-(R*,S*))-; (5R)-5-[(1S)-1,5-dimethylhex-4-enyl]-2-methylcyclohexa-1,3-diene; (5S)-5-[(1R)-1,5-dimethyl-4-hexenyl]-2-methyl-1,3-cyclohexadiene; (5R)-5-[(1S)-1,5-dimethylhex-4-enyl]-2-methyl-cyclohexa-1,3-diene; (S-(R*,S*))-5-(1,5-Dimethylhexen-4-yl)-2-methyl-1,3-cyclohexa-1,3-diene; AKOS015968402; Zingiberene; (5S)-2-Methyl-5-[(1R)-1,5-dimethyl-4-hexenyl]-1,3-cyclohexadiene; alpha-Zingiberene; [S-(R*,S*)]-5-(1,5-dimethylhexen-4-yl)-2-methyl-1,3-cyclohexa-1,3-diene; EINECS 207-804-2; LMPR01030039; ent-Zingiberene; ZINC44431718; (5R)-2-methyl-5-[(2S)-6-methylhept-5-en-2-yl]cyclohexa-1,3-diene; C09750; (5S)-2-methyl-5-[(2R)-6-methylhept-5-en-2-yl]cyclohexa-1,3-diene; CHEBI:583099; (+)-zingiberene | C15H24 | 204.35 g/mol | CC1=CCC(C=C1)C(C)CCC=C(C)C |
| TCMBANKIN023973 | penduletin | 4H-1-Benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-3,6,7-trimethoxy-; W1676; 5-Hydroxy-2-(4-hydroxyphenyl)-3,6,7-trimethoxy-4H-chromen-4-one #; LMPK12112874; CTK1H1732; MolPort-035-705-982; SCHEMBL2217068; 5-hydroxy-2-(4-hydroxyphenyl)-3,6,7-trimethoxychromen-4-one; 5-Hydroxy-2-(4-hydroxy-phenyl)-3,6,7-trimethoxy-chromen-4-one; penduletin ; 2-(4-Hydroxyphenyl)-3,6,7-trimethoxy-5-hydroxy-4H-1-benzopyran-4-one (penduletin); 5-Hydroxy-2-(4-hydroxyphenyl)-3,6,7-trimethoxy-4H-1-benzopyran-4-one; 5,4'-Dihydroxy-3,6,7-trimethoxyflavone; CHEMBL165509; Penduletin; AKOS032948446; 5-hydroxy-2-(4-hydroxyphenyl)-3,6,7-trimethoxy-chromen-4-one; 569-80-2; 5-hydroxy-2-(4-hydroxyphenyl)-3,6,7-trimethoxy-4-chromenone; 5-Hydroxy-2-(4-hydroxyphenyl)-3,6,7-trimethoxy-4H-chromen-4-one; YSXFFLGRZJWNFM-UHFFFAOYSA-N; BG01632786; 5-hydroxy-2-(4-hydroxyphenyl)-3,6,7-trimethoxy-chromone; AC1NSZHZ; DTXSID00205437; 5,4''-dihydroxy-3,6,7-trimethoxyflavanone; BDBM50338973; ZINC14644952 | C18H16O7 | 344.3 g/mol | COC1=C(C(=C2C(=C1)OC(=C(C2=O)OC)C3=CC=C(C=C3)O)O)OC |
| TCMBANKIN028147 | (?)-Solanone | C13H22O | 194.31 g/mol | CC(C)C(CCC(=O)C)C=CC(=C)C | |
| TCMBANKIN028868 | neonootkatol | 314.46 | COC1=C(C=CC(=C1)CC(CCCCCC2=CC=CC=C2)O)O | ||
| TCMBANKIN029851 | tunefulin | C20H26O7 | 378.42 | ||
| TCMBANKIN030984 | neopetasone | (3R,4aR,5S)-4a,5-dimethyl-3-prop-1-en-2-yl-3,4,5,6,7,8-hexahydronaphthalen-2-one; 13902-42-6; Eremophyla-9,11-dien-8-one; Neopetasane; DIZRSLUNVNGBPA-NJZAAPMLSA-N; AC1NSZ2P; SCHEMBL7711305 | C15H22O | 218.33 g/mol | CC1CCCC2=CC(=O)C(CC12C)C(=C)C |
| TCMBANKIN034821 | chrysanthenone | Chrysanthenone, (+)-; 38301-80-3; Bicyclo(3.1.1)hept-2-en-6-one, 2,7,7-trimethyl-, (1S,5R)-; UNII-5706LMQ84R; Chrysanthenone D-form [MI]; Biscyclo(3.1.1)hept-2-en-6-one, 2,7,7-trimethyl-; UNII-841NXH6XEV component IECBDTGWSQNQID-JGVFFNPUSA-N; 5706LMQ84R | C10H14O | 150.22 | CC1=CCC2C(=O)C1C2(C)C |
| TCMBANKIN036831 | Tectochrysin | NSC80687; 5-hydroxy-7-methoxy-2-phenyl-chromone; IDI1_014606; AIDS-059327; 7-Methoxy-5-hydroxyflavone; Flavone, 5-hydroxy-7-methoxy-; Oprea1_215176; BAS 00872586; 4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-phenyl-; Flavone, 5-hydroxy-7-methoxy- (8CI); Maybridge3_003219; SMR000387029; 5-Hydroxy-7-methoxyflavone; MLS000697658; 5-hydroxy-7-methoxy-2-phenylchromen-4-one; Oprea1_023530; C11621; TNP00038; NCGC00142540-01; ZINC00042243; MLS001049041; NCGC00017176-01; 4H-1-Benzopyran-4-one, 5-hydroxy-7-methoxy-2-phenyl- (9CI); NSC 80687; 520-28-5; SR-01000402578-2; ST057541; Techtochrysin; AIDS059327; 5-hydroxy-7-methoxy-2-phenyl-4-chromenone; tectochrysin; 5-Hydroxy-7-methoxy-2-phenyl-chromen-4-one | 268.26 | ||
| TCMBANKIN037164 | Indicumenone | Indicumenone; CHEBI:81218; C17612 | 252.35 | ||
| TCMBANKIN037169 | Oxyphyllol A | 7-Isopropenyl-1,4a-dimethyl-1,2,3,4,4a,5,6,7-octahydro-naphthalen-1-ol; 1-naphthalenol, 1,2,3,4,4a,5,6,7-octahydro-1,4a-dimethyl-7-(1-methylethenyl)-, (1R,4aR,7R)-; (1R,4aR,7R)-1,4a-dimethyl-7-prop-1-en-2-yl-2,3,4,5,6,7-hexahydronaphthalen-1-ol; oxyphyllol a; (1R,4aR,7R)-7-isopropenyl-1,4a-dimethyl-2,3,4,5,6,7-hexahydronaphthalen-1-ol; InChI=1/C15H24O/c1-11(2)12-6-9-14(3)7-5-8-15(4,16)13(14)10-12/h10,12,16H,1,5-9H2,2-4H3/t12-,14-,15-/m1/s; rel-(1R,4aR,7R)-7-isopropenyl-1,4a-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-1-ol | C30H39Cl2N5O4S2 | 668.7 | CC(=C)C1CCC2(CCCC(C2=C1)(C)O)C |
| TCMBANKIN037283 | 6-Isopropenyl-4,8a-dimethyl-1,2,3,5,6,7,8,8a-octahydro-naphthalen-2-ol | 6-isopropenyl-4,8a-dimethyl-1,2,3,5,6,7,8,8a-octahydro-naphthanlen-2-ol | C15H24O | 220.35 | C1([H])([H])[C@@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@@]([H])(C(C([H])([H])[H])=C([H])[H])C2([H])[H])C2=C(C([H])([H])[H])C([H])([H])[C@@]1([H])O[H] |
| TCMBANKIN040452 | Oxyphyllenone B | oxyphyllenone b | 210.27 | ||
| TCMBANKIN040544 | Nootkatone | (4R,4aS,6R)-4,4a,5,6,7,8-hexahydro-4,4a-dimethyl-6-(1-methylethenyl)naphthalen-2(3H)-one | 216.362 | ||
| TCMBANKIN040663 | spiro[4,4]nonane-2-one | C9H14O | C1CCC2(C1)CCC(=O)C2 | ||
| TCMBANKIN041062 | yakuchinone b | 1-Hepten-3-one, 1-(4-hydroxy-3-methoxyphenyl)-7-phenyl-, (1E)-; yakuchinone-b; 81840-57-5; (1E)-1-(4-Hydroxy-3-methoxyphenyl)-7-phenyl-1-hepten-3-one; (E)-1-(4-hydroxy-3-methoxy-phenyl)-7-phenyl-hept-1-en-3-one; 1-(4'-hydroxy-3'-methoxyphenyl)-7-phenylhept-1-en-3-one; (E)-1-(4-hydroxy-3-methoxyphenyl)-7-phenylhept-1-en-3-one | C20H22O3 | 310.39 | COC1=C(C=CC(=C1)C=CC(=O)CCCCC2=CC=CC=C2)O |
| TCMBANKIN041292 | Oxyphyllenodiol A | 238.32 g/mol | |||
| TCMBANKIN042313 | Oxyphyllenone A | 210.27 g/mol | |||
| TCMBANKIN043081 | Isocyperol | CZFHAODYOVXPIQ-FFHGMXDLSA-N; CHEMBL489542; Isocyperol | 220.35 g/mol | ||
| TCMBANKIN045600 | oxyphyllol c | C15H26O2 | 238.37 g/mol | CC1CCC(C2(C1(CC(CC2)C(=C)C)C)O)O | |
| TCMBANKIN047882 | oxyphyllol b | C15H22O2 | 234.33 g/mol | CC1CC(=O)C=C2C1(CC(CC2O)C(=C)C)C | |
| TCMBANKIN048796 | Oxyphyllenodiol B | 1(2H)-Naphthalenone, 3,4,5,6,7,8-hexahydro-5,6-dihydroxy-6-methyl-4-(1-methylethyl)-, (4R,5S,6R)-; (4R,5S,6R)-5,6-dihydroxy-6-methyl-4-propan-2-yl-2,3,4,5,7,8-hexahydronaphthalen-1-one; (4R,5S,6R)-5,6-dihydroxy-4-isopropyl-6-methyl-2,3,4,5,7,8-hexahydronaphthalen-1-one; AIDS314128; oxyphyllenodiol b; AIDS-314128 | 238.32 | ||
| TCMBANKIN050297 | Nootkatol | 220.35 | |||
| TCMBANKIN058175 | hydroxyresveratrol | 2,4,3',5'-Tetrahydroxystilbene; oxyresveratrol ; Cudranin; oxyresveratrol; 2,3',4,5'-tetrahydroxystilbene; trans-2,3',4,5'-tetrahydroxystilbene; TETRAHYDROXYSTILBENE; Puag-haad; ACon1_001063; 1,3-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, (E)-; 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,3-diol; NSC 315550; 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol; 4-[2-(3,5-dihydroxyphenyl)vinyl]resorcinol; Oxyresveratrol; cudranin; C10273; 1,3-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-; MEGxp0_001057; 4-[2-(3,5-dihydroxyphenyl)vinyl]benzene-1,3-diol; 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]resorcinol; NSC315550; 4-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol; 4721-07-7; 29700-22-9 | C14H12O4 | 244.24 g/mol | C1=CC(=C(C=C1O)O)C=CC2=CC(=CC(=C2)O)O |
| TCMBANKIN058267 | vitamin b | NSC169454; SR-01000722017-4; Nicotinic acid, >=98%; [3H]nicotinic acid; Nicotinamide (JP15/INN); AC1Q73P3; C6H5NO2; 11054-EP2289510A1; NCGC00094734-02; AB00052050; HMS3655K08; Efacin; Nico-400; N1103; 11054-EP2298772A1; TR-032523; C00253; Nicosan 3; SPBio_000011; Nicotinic Acid [Matrix for MALDI-TOF/MS]; SPBio_002881; 5-22-02-00057 (Beilstein Handbook Reference); Niacinamide Astra Brand; Spectrum3_000515; ANW-75276; Bionic; 11054-EP2301923A1; SDCCGMLS-0066610.P001; Nicotinsaure [German]; Nicotinic acid, >=99.5% (HPLC); preventative factor; 28029-53-0 (cobalt(2+) salt); SR-01000722017-3; Acide nicotinique [INN-French]; 11054-EP2295409A1; NICO; InChI=1/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9; D00049; Jenapharm Brand of Niacinamide; Nicotinamide (TN); Niacin [USAN]; bmse000104; 1976-28-9 (aluminum salt); 11054-EP2311816A1; Apelagrin; AN-23622; KBio2_001543; ABT-919; Acido nicotinico; .beta.-Pyridinecarboxylic acid; Niaspan (TN); 11054-EP2270002A1; SR-01000722017-2; KB-33243; Pellagramin; NCGC00016268-02; DSSTox_CID_932; Merck Brand of Niacinamide; nicobid; beta-pyridinecarboxylic acid; BDBM23515; 3PyrCOOH; Nicotinic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, >=98%; Pellagra preventive factor; niacin; Prestwick0_000881; Nicotinic acid, Ph Eur; BPBio1_000730; Nicacid; UNII-2679MF687A; EBD2198325; NCGC00016268-08; 3-Carboxypyridine; ST097540; Z56755709; Davitamon PP; Nicotinamide (Niacinamide); Nicotinic acid, analytical standard; CPD000059024; 3-Pyridylcarboxylic acid; Pyridine-beta-carboxylic acid; KBioSS_001543; 11054-EP2305674A1; Nicotinic acid, for synthesis, 99%; Nicodon; Oprea1_514398; [5, 6-3H]-niacin; 636-79-3 (hydrochloride); Direktan; Niacin (Nicotinic Acid), Pharmaceutical Secondary Standard; Certified Reference Material; DB-007765; 11054-EP2298742A1; Nyclin; 11054-EP2316827A1; NSC-169454; 7069-06-9 (magnesium salt); 11054-EP2316826A1; Niacor; niacine; MLS000069603; AC-907/25014105; GTPL1594; Spectrum5_001287; RP00705; niacin potassium; BSPBio_002069; STR00112; IDI1_000695; LS-2334; AM81316; NAH; P.P. factor-pellagra preventive factor; AC-22484; Vitaplex N; Nicodan; 3789-96-6 (tartrate); 11054-EP2311829A1; AB1002056; Niacinamide Merck Brand; Spectrum4_000965; Pyridinecarboxylic acid, 3-; CCRIS 1902; 11054-EP2308838A1; SBI-0051456.P003; 11054-EP2280001A1; Nicotinic acid [INN]; PubChem2594; Nicovasen; 54-86-4 (hydrochloride salt); 11054-EP2274983A1; 11054-EP2308854A1; NCGC00016268-04; MCULE-3788394698; Nicagin; nicolar; NIASPAN TITRATION STARTER PACK; AB00052050-13; ST2413625; J-523605; 36321-41-2 (ammonium salt); Acido nicotinico [INN-Spanish]; Akotin; EINECS 200-441-0; SBB004279; 11054-EP2311830A1; Niacin, United States Pharmacopeia (USP) Reference Standard; Acidum nicotinicum; Nikasan; SR-01000722017; AK-46486; Enduracin; CS-1946; Nicotinic acid, certified reference material, TraceCERT(R); Induracin; Nico-Span; antipellagra vitamin; 3-pyridine carboxylic acid; Nicoside; Nicotinic acid, purum, >=99.0% (HPLC); CHEMBL573; Pyridylcarboxylic Acid; Tinic; 11054-EP2295424A1; EPA Pesticide Chemical Code 056701; Nicotine acid; Ncotnc acd; 11054-EP2305651A1; pellagra; Nicorol; 5-pyridinecarboxylic acid; NCGC00094734-01; 11054-EP2298776A1; 3-Picolinic acid; Niacin; Pellagra preventive factor; Pyridine-3-carboxylic acid; Vitamin B3; KBioGR_001309; 11054-EP2308848A1; KSC236Q9T; Nipellen; Niacin (USP); 3-pyridinecarboxylic acid; Vitamin B3 (Niacin); KBio2_006679; NCI60_001041; HMS2236A05; AB00052050_14; Nicotinic acid, matrix substance for MALDI-MS, >=99.5% (HPLC); HMS2097B04; Spectrum2_000006; 99148-57-9 (tosylate); SCHEMBL1433; BSPBio_000662; MolPort-000-142-273; KBio3_001569; 10361-13-4 (iron(2+) salt); Tox21_110337_1; F2191-0082; Acide nicotinique; Nicotinic acid, European Pharmacopoeia (EP) Reference Standard; 11054-EP2269990A1; 11054-EP2308858A1; M-5918; 11054-EP2275401A1; Nicotinic acid, plant cell culture tested; Nicotinic acid, SAJ special grade, >=99.5%; Niacinamide (TN); HMS3714B04; STK301803; Pelonin; Niconazid; Prestwick2_000881; Nicovasan; 11054-EP2270014A1; Niacinamide Pharmagenix Brand; Pharmakon1600-01500430; Pyridine-carboxylique-3 [French]; SK-Niacin; Prestwick1_000881; Nikazan; EC 200-441-0; PP Factor; AKOS000118980; HY-B0143; Tox21_110337; HMS3371E07; WLN: T6NJ CVQ; Nicotene; Nicotinic acid [INN:BAN]; CAS-59-67-6; 11054-EP2316458A1; Kyselina nikotinova [Czech]; P.P. factor; Pyridine-3-carboxylic acid; Niacin (nicotinic acid); Tox21_201420; L001199; NCGC00016268-09; nicocap; I02-0699; nicotinic acid; Niconat; ZINC1795; Niacin [USP]; Diacin; 11054-EP2272825A2; Kyselina nikotinova; FC1287; Nicotinic acid-d3(major); CHEBI:15940; 823-77-8 (calcium salt); Niacor (TN); DSSTox_RID_75875; NCGC00256537-01; Nicotamin; GTPL1588; 2679MF687A; ACMC-1AS6M; [3H]-Nicotinic acid; SPECTRUM1500430; Acidum nicotinicum [INN-Latin]; HMS1570B04; 11054-EP2301937A1; KBio1_000695; BP-21419; Niacinamide Jenapharm Brand; AJ-08093; Nicotinic acid, NIST(R) SRM(R) 148; niacin magnesium; Nicyl; S115; Tega-Span; 11054-EP2269610A2; KBio2_004111; AC1L1AD5; NCGC00016268-01; Niacinamide, Nicotinic acid amide, Nicotinamide; Opera_ID_1346; Nicotinic acid, 99% 250g; 3-Pyridyl carboxylic acid; Nicocidin; nicotinate; s1744; SR 4390; DTXSID1020932; Nicotinsaure; 16518-17-5 (potassium salt); Nicotinic acid, Vetec(TM) reagent grade, >=98%; 11054-EP2308839A1; Linic; BIDD:GT0644; NC00524; wampocap; NCGC00016268-03; Nicotinic acid, for inorganic trace analysis, >=99.999% (metals basis); AB00052050_15; Nicosyl; CCG-38340; D06NVJ; 11054-EP2301935A1; 11054-EP2308874A1; Nikotinsaeure; SC-05611; Pyridine-3-carbonic acid; Nicodelmine; 53890-72-5 (lithium salt); 11054-EP2311808A1; SMR000059024; Daskil; NSC 169454; MFCD00006391; PS-4255; HMS502C17; 11054-EP2272848A1; FT-0082580; Pyridine-.beta.-carboxylic acid; DivK1c_000695; 11054-EP2295406A1; Niacin-Vitamin B3; N0082; BRN 0109591; 3-Carboxylpyridine; 11054-EP2316828A1; Niac; NCGC00258971-01; 3-Picolinic acid; 11054-EP2292610A1; NINDS_000695; 11054-EP2292228A1; FT-0600004; Astra Brand of Niacinamide; Nicotinic Acid 1.0 mg/ml in Methanol; 11054-EP2272834A1; HMS3259K21; Niacin (TN); Nicotinic acid (JP17/INN); NSC-757241; Prestwick3_000881; Niaspan; Slo-niacin; SAM002554917; HMS2091H22; Pharmagenix Brand of Niacinamide; 59-67-6; NCGC00016268-05; Tox21_302904; Pellagrin; Caswell No. 598; 11054-EP2277848A1; 3DDB011E-F3A6-45B6-A2D2-77B2A6E8936E; 11054-EP2301929A1; 11054-EP2311817A1; Naotin; m-Pyridinecarboxylic acid; vitamin B3; HSDB 3134; Peviton; nicamin; Nicotinic acid (Vitamin B3) solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; Nicangin; Spectrum_001063; Pyridine-carboxylique-3; KB-259513; 11054-EP2298779A1; Nicocrisina; DB00627; 11054-EP2316825A1; AI3-18994; PVNIIMVLHYAWGP-UHFFFAOYSA-N; 11054-EP2316457A1; I14-92791; anti-Pellagra vitamin; 28029-54-1 (manganese(2+) salt); NSC757241; 123574-58-3; Nicotil; HMS1920P17; Nicotinipca; 3-Pyridinecarboxylicacid; 11054-EP2314588A1; Niconacid; NIO; Nicotinic acid, meets USP testing specifications; DSSTox_GSID_20932; Nicotinamide-carbonyl-14C | C5H4NCOOH | 123.11 g/mol | C1=CC(=CN=C1)C(=O)O |
| TCMBANKIN059531 | eucalyptol | C10H18O | 154.25 g/mol | CC1(C2CCC(O1)(CC2)C)C | |
| TCMBANKIN059658 | labdadiene | C20H30O2 | 302.5 g/mol | CC1(CCCC2(C1CCC(=C)C2CC=C(CC=O)C=O)C)C | |
| TCMBANKIN060271 | acacetin-7-O-rutinoside | C28H32O14 | 592.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)OC)O)O)O)O)O)O)O | |
| TCMBANKIN060910 | cis-9-hexadecenoic acid | C16H30O2 | 254.41 g/mol | CCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061128 | n-tetracosanoic acid | C24H48O2 | 368.64 g/mol | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061630 | 1-(4’-hydroxy-3’-methoxyphenyl)-7-phenyl-3-heptanone | 1-(4’-hydroxy-3’-methoxyphenyl)-7-phenyl-3-heptanone | COC1=C(C=CC(=C1)CCC(=O)CCCCC2=CC=CC=C2)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab